Rhode Island 2022 Regular Session

Rhode Island Senate Bill S2890

Introduced
4/26/22  

Caption

Senate Resolution Supporting Improvements In The Care Of Atherosclerotic Cardiovascular Disease

Impact

The passage of S2890 would lead to changes within the state’s healthcare policy framework, specifically encouraging the Rhode Island Department of Health to expand cholesterol screening programs. By advocating for an updated cardiovascular plan, the bill aims to establish a more coordinated approach to treating patients with ASCVD. The resolution addresses not only treatment but the importance of preventive measures, aiming to reduce the economic burden associated with cardiovascular disease care, which is currently estimated in the hundreds of millions of dollars each year.

Summary

Senate Bill S2890 focuses on addressing the significant public health challenge posed by atherosclerotic cardiovascular disease (ASCVD) in Rhode Island. By acknowledging that cardiovascular disease is the leading cause of death in the U.S., the bill urges state agencies to take proactive steps to improve care for those suffering from this condition. The resolution highlights the alarming statistics surrounding ASCVD, including high prevalence and projected increases, framing the need for improved strategies to combat these issues effectively. A key goal of the bill is to enhance cholesterol screening and overall cardiovascular health management among residents.

Sentiment

Overall, the sentiment surrounding S2890 is positive, as it seeks to directly address a pressing health issue that affects thousands of residents. Stakeholders, including healthcare professionals and advocacy groups, likely view the resolution as a necessary step towards enhancing patient outcomes and implementing systematic changes to healthcare practices. The intent of the bill resonates with broader public health goals, aiming to take a proactive stance in managing chronic diseases such as ASCVD.

Contention

A potential point of contention may arise regarding the funding and implementation of the proposed screening expansions and policy enhancements. Questions could be raised about resource allocation, possible bureaucracy, and the effectiveness of the proposed measures. Furthermore, while the bill presents a united front in combating ASCVD, it may face scrutiny concerning the political will to prioritize public health initiatives amid competing legislative interests.

Companion Bills

No companion bills found.

Previously Filed As

RI H8109

House Resolution Supporting Improvements In The Care Of Atherosclerotic Cardiovascular Disease

RI HR336

Supporting the improvement of the care of atherosclerotic cardiovascular disease; commend

RI S1964

Resolutions to improve the care of atherosclerotic cardiovascular disease

RI H3543

Resolutions to improve the care of atherosclerotic cardiovascular disease

RI SR372

Atherosclerotic Cardiovascular Disease; improvement of care; support

RI ACR67

Atherosclerotic cardiovascular disease (ASCVD).

RI SJR0044

A RESOLUTION relative to improving the care of atherosclerotic cardiovascular disease.

RI SR412

Atherosclerotic Cardiovascular Disease; support the improvement

RI H8069

Atherosclerotic Cardiovascular Disease Awareness Month

RI SR56

Designating the month of February 2023 as "Atherosclerotic Cardiovascular Disease Month" in Pennsylvania.

Similar Bills

No similar bills found.